Product Information

VALSARTAN-HYDROCHLOROTHIAZIDE 160-25 MG TAB is a generic product labeled by Solco Healthcare US LLC, priced at $0.1245 per EA under NDC 43547031309. Its NADAC has been published 472 times since Jun 29, 2016.

FDA first approved this application on Feb 8, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

VALSARTAN-HYDROCHLOROTHIAZIDE 160-25 MG TAB

valsartan and hydrochlorothiazide
$0.1245per EA

Strength

25; 160 mg/1; mg/1

NDC

43547031309

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA206083

FDA Approved

2/8/2016

TE Code

AB

On Market Since

10/31/2015

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Increased Diuresis
Thiazide Diuretic
Thiazides

Price Statistics

The NADAC for VALSARTAN-HYDROCHLOROTHIAZIDE 160-25 MG TAB has been published 472 times since Jun 29, 2016, and over the history we have for it it has declined 53.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1245 per EA
All-time high$0.4435 (Sep 16, 2020)
All-time low$0.1245 (Aug 19, 2026)
52-week high$0.1680
52-week low$0.1245
Median price$0.2131
Average price$0.2305
Largest weekly change+39.6% (Aug 21, 2024)
Weeks tracked472
Tracking sinceJun 29, 2016

Price History

1W

-3.4%

1M

-3.4%

3M

-12.4%

6M

-14.0%

1Y

-25.9%

3Y

-42.9%

5Y

-66.0%

All

-53.2%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of VALSARTAN-HYDROCHLOROTHIAZIDE 160-25 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for VALSARTAN-HYDROCHLOROTHIAZIDE 160-25 MG TAB, manufactured by Solco Healthcare US LLC, is $0.1245 per EA (NDC 43547031309), effective Aug 19, 2026.

How has the price of VALSARTAN-HYDROCHLOROTHIAZIDE 160-25 MG TAB changed over time?

Over the history we have for it, the NADAC for VALSARTAN-HYDROCHLOROTHIAZIDE 160-25 MG TAB has declined 53.2%. It has been tracked across 472 weekly CMS publications since Jun 29, 2016.

What are the highest and lowest recorded NADAC prices for VALSARTAN-HYDROCHLOROTHIAZIDE 160-25 MG TAB?

Since Jun 29, 2016, the NADAC for VALSARTAN-HYDROCHLOROTHIAZIDE 160-25 MG TAB has ranged from a low of $0.1245 (Aug 19, 2026) to a high of $0.4435 (Sep 16, 2020), with a median of $0.2131 per EA.

Are there cheaper alternatives to VALSARTAN-HYDROCHLOROTHIAZIDE 160-25 MG TAB?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as VALSARTAN-HYDROCHLOROTHIAZIDE 160-25 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures VALSARTAN-HYDROCHLOROTHIAZIDE 160-25 MG TAB?

VALSARTAN-HYDROCHLOROTHIAZIDE 160-25 MG TAB (NDC 43547031309) is labeled by Solco Healthcare US LLC, and CMS classifies it as a generic product.